Amylyx Pharmaceuticals · 23 hours ago
Director, Launch Excellence
Amylyx is a clinical-stage company focused on treating diseases with high unmet needs, including post-bariatric hypoglycemia and ALS. They are seeking a Director, Launch Excellence to lead the planning and execution of their first product launch in the endocrinology space, coordinating across multiple functions to ensure launch readiness.
BiotechnologyMedicalNeurosciencePharmaceutical
Responsibilities
Lead the end-to-end launch execution plan, including timelines, milestones, dependencies, and risk mitigation activities
Translate high-level launch strategy into actionable, trackable workstreams with clear ownership
Maintain and continuously refine integrated launch plans from pre-approval through post-launch phases
Act as the single point of coordination across all launch-related functions
Facilitate regular launch governance forums (e.g., launch team meetings, executive readouts)
Ensure continuous alignment across Commercial, Medical Affairs, Market Access, Supply Chain, Regulatory, and other key stakeholders
Proactively identify launch risks, gaps, and interdependencies; develop mitigation plans and escalate as needed
Track launch readiness metrics and ensure timely decision-making
Support scenario planning tied to regulatory timing, supply readiness, and market dynamics
Implement and manage launch project management tools, dashboards, and reporting mechanisms
Drive consistent ways of working, documentation standards, and decision logs
Prepare detailed and clear executive-level communications and launch status updates
Capture lessons learned and best practices to support future indications or lifecycle expansion
Help build scalable launch excellence capabilities appropriate for a growing biotech organization
Qualification
Required
Bachelor's degree required; advanced degree (MBA, MPH, MS) preferred
10+ years of experience in pharmaceutical or biotech launch, commercial operations, or enterprise project management
Direct experience supporting product launch readiness in the U.S. market
Proven ability to lead complex, cross-functional initiatives without direct authority
Strong organizational, communication, and stakeholder management skills
Fluency with project management tracking tools (e.g., MS Project, Smartsheets, MS Excel), and advanced MS PowerPoint skills
Comfortable operating in ambiguity and adapting as strategy and timelines evolve
Preferred
Advanced degree (MBA, MPH, MS)
Company
Amylyx Pharmaceuticals
Amylyx Pharmaceuticals specializes in providing solutions for Alzheimer’s and other diseases of the brain.
Funding
Current Stage
Public CompanyTotal Funding
$623.45MKey Investors
Viking Global InvestorsMorningside
2025-09-10Post Ipo Equity· $175M
2022-10-06Post Ipo Equity· $246.3M
2022-01-07IPO
Recent News
BioWorld Financial Watch
2026-01-11
Longevity.Technology
2026-01-11
Company data provided by crunchbase